AUTO3 CD19/CD22 CAR T cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AUTO3 CD19/CD22 CAR T cells, covering 2025-07-14 to 2025-07-14. Get the full timeline:
Most recent: Clinical Trial Update: Cluster of Differentiation Antigen 19/22(CD19/22) CAR T Cells (AUTO3) for the Treatment of Diffuse Large B Cell Lymphoma [Phase 1, Phase 2]